Literature DB >> 19825803

Tubulin-based antimitotic mechanism of E7974, a novel analogue of the marine sponge natural product hemiasterlin.

Galina Kuznetsov1, Karen TenDyke, Murray J Towle, Hongsheng Cheng, Junke Liu, Joanne P Marsh, Shawn E R Schiller, Mark R Spyvee, Hu Yang, Boris M Seletsky, Christina J Shaffer, Veronique Marceau, Ye Yao, Edward M Suh, Silvio Campagna, Francis G Fang, James J Kowalczyk, Bruce A Littlefield.   

Abstract

E7974 is a synthetic analogue of the marine sponge natural product hemiasterlin. Here, we show that E7974, such as parental hemiasterlin, acts via a tubulin-based antimitotic mechanism. E7974 inhibits polymerization of purified tubulin in vitro with IC(50) values similar to those of vinblastine. In cultured human cancer cells, E7974 induces G(2)-M arrest and marked disruption of mitotic spindle formation characteristic of tubulin-targeted anticancer drugs. Extensive hypodiploid cell populations are seen in E7974-treated cells, indicating initiation of apoptosis after prolonged G(2)-M blockage. Consistent with this observation, E7974 induces caspase-3 activation and poly ADP ribose polymerase cleavage, typical biochemical markers of apoptosis. Only a short cellular exposure to E7974 is sufficient to induce maximum mitotic arrest, suggesting that E7974's antitumor effects in vivo may persist even after blood levels of the drug decrease after drug administration. Interactions of E7974 with purified tubulin were investigated using two synthetic tritiated photoaffinity analogues incorporating a benzophenone photoaffinity moiety at two different positions of the E7974 scaffold. Both analogues preferentially photolabeled alpha-tubulin, although minor binding to beta-tubulin was also detected. E7974 thus seems to share a unique, predominantly alpha-tubulin-targeted mechanism with other hemiasterlin-based compounds, suggesting that, unlike many tubulin-targeted natural products and related drugs, the hemiasterlins evolved to mainly target alpha-tubulin, not beta-tubulin subunits.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19825803     DOI: 10.1158/1535-7163.MCT-09-0301

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  17 in total

Review 1.  Eribulin -- a review of preclinical and clinical studies.

Authors:  Umang Swami; Imran Chaudhary; Mohammad H Ghalib; Sanjay Goel
Journal:  Crit Rev Oncol Hematol       Date:  2011-04-14       Impact factor: 6.312

2.  Hemiasterlin analogues incorporating an aromatic, and heterocyclic type C-terminus: design, synthesis and biological evaluation.

Authors:  Giordano Lesma; Alessandro Sacchetti; Rouli Bai; Giuseppe Basso; Roberta Bortolozzi; Ernest Hamel; Alessandra Silvani; Nadia Vaiana; Giampietro Viola
Journal:  Mol Divers       Date:  2014-02-06       Impact factor: 2.943

3.  Complementary isonitrile-based multicomponent reactions for the synthesis of diversified cytotoxic hemiasterlin analogues.

Authors:  Giordano Lesma; Ivan Bassanini; Roberta Bortolozzi; Chiara Colletto; Ruoli Bai; Ernest Hamel; Fiorella Meneghetti; Giulia Rainoldi; Mattia Stucchi; Alessandro Sacchetti; Alessandra Silvani; Giampietro Viola
Journal:  Org Biomol Chem       Date:  2015-10-15       Impact factor: 3.876

4.  Development of hemiasterlin derivatives as potential anticancer agents that inhibit tubulin polymerization and synergize with a stilbene tubulin inhibitor.

Authors:  Lih-Ching Hsu; David E Durrant; Ching-Chun Huang; Nai-Wen Chi; Riccardo Baruchello; Riccardo Rondanin; Cinzia Rullo; Paolo Marchetti; Giuseppina Grisolia; Daniele Simoni; Ray M Lee
Journal:  Invest New Drugs       Date:  2011-06-08       Impact factor: 3.850

5.  Synthesis and anti-cancer screening of novel heterocyclic-(2H)-1,2,3-triazoles as potential anti-cancer agents.

Authors:  Narsimha Reddy Penthala; Leena Madhukuri; Shraddha Thakkar; Nikhil Reddy Madadi; Gauri Lamture; Robert L Eoff; Peter A Crooks
Journal:  Medchemcomm       Date:  2015-06-30       Impact factor: 3.597

Review 6.  Bioactive compounds from marine invertebrates as potent anticancer drugs: the possible pharmacophores modulating cell death pathways.

Authors:  Srimanta Patra; Prakash Priyadarshi Praharaj; Debasna Pritimanjari Panigrahi; Biswajit Panda; Chandra Sekhar Bhol; Kewal Kumar Mahapatra; Soumya Ranjan Mishra; Bishnu Prasad Behera; Mrutyunjay Jena; Gautam Sethi; Shankargouda Patil; Samir Kumar Patra; Sujit Kumar Bhutia
Journal:  Mol Biol Rep       Date:  2020-08-14       Impact factor: 2.316

7.  Potent cytotoxic peptides from the Australian marine sponge Pipestela candelabra.

Authors:  Trong D Tran; Ngoc B Pham; Gregory A Fechner; John N A Hooper; Ronald J Quinn
Journal:  Mar Drugs       Date:  2014-06-04       Impact factor: 5.118

Review 8.  Current Status of Marine-Derived Compounds as Warheads in Anti-Tumor Drug Candidates.

Authors:  David J Newman; Gordon M Cragg
Journal:  Mar Drugs       Date:  2017-03-29       Impact factor: 5.118

Review 9.  Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery.

Authors:  Jin-Young Lee; Barbora Orlikova; Marc Diederich
Journal:  Mar Drugs       Date:  2015-08-07       Impact factor: 5.118

10.  Combretastatin A-4 efficiently inhibits angiogenesis and induces neuronal apoptosis in zebrafish.

Authors:  Yun-Wei Shi; Wei Yuan; Xin Wang; Jie Gong; Shun-Xing Zhu; Lin-Lin Chai; Jia-Ling Qi; Yin-Yin Qin; Yu Gao; Yu-Ling Zhou; Xiao-Le Fan; Chun-Ya Ji; Jia-Yi Wu; Zhi-Wei Wang; Dong Liu
Journal:  Sci Rep       Date:  2016-07-25       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.